BioCardia, Inc. — Investor Relations & Filings
BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2020 | 2020-10-15 | English | |
| FORM 4 | 2020-10-09 | English | |
| FORM 4 | 2020-10-09 | English | |
| FORM 4 | 2020-10-09 | English | |
| FORM 4 | 2020-10-09 | English | |
| FORM 4 | 2020-10-09 | English |
Browse filings by year
24 years- 2026 18 filings
- 2025 106 filings
- 2024 84 filings
- 2023 83 filings
- 2022 59 filings
- 2021 62 filings
- 2020 105 filings
- 2019 83 filings
- 2018 60 filings
- 2017 51 filings
- 2016 44 filings
- 2015 8 filings
- 2014 12 filings
- 2013 16 filings
- 2012 6 filings
- 2011 38 filings
- 2010 27 filings
- 2009 28 filings
- 2008 47 filings
- 2007 25 filings
- 2006 7 filings
- 2005 20 filings
- 2004 22 filings
- 2003 11 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 10251235 | Regulatory Filings 2020 | 2020-10-15 | English | ||
| 10251236 | FORM 4 | 2020-10-09 | English | ||
| 10251237 | FORM 4 | 2020-10-09 | English | ||
| 10251239 | FORM 4 | 2020-10-09 | English | ||
| 10251240 | FORM 4 | 2020-10-09 | English | ||
| 10251241 | FORM 4 | 2020-10-09 | English | ||
| 10251242 | FORM 4 | 2020-10-09 | English | ||
| 10251244 | FORM 4 | 2020-10-09 | English | ||
| 10251247 | FORM S-3 | 2020-10-09 | English | ||
| 10251251 | FORM 8-K | 2020-10-09 | English | ||
| 10251249 | FORM 8-K | 2020-08-13 | English | ||
| 10251255 | FORM 10-Q | 2020-08-13 | English | ||
| 10251256 | FORM 8-K | 2020-07-07 | English | ||
| 10251257 | FORM 4 | 2020-07-01 | English | ||
| 10251261 | FORM 4 | 2020-07-01 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BioCardia, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35081/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35081 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35081 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35081 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35081}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioCardia, Inc. (id: 35081)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.